НовостиBenzingaOppenheimer Maintains Outperform on Pelthos Therapeutics, Lowers Price Target to $59 Oppenheimer Maintains Outperform on Pelthos Therapeutics, Lowers Price Target to $59 Benzinga 2026.11.13 15:39 (GMT+0) Открыть на Benzinga Другие новости